UroGen Pharma Ltd. (URGN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.13B |
| Enterprise Value | 1.14B |
| P/E Ratio | -18.6 |
| PEG Ratio | -0.37 |
| Price/Sales Ratio | 9.51 |
| Price/Book Ratio | -14.01 |
| Enterprise/Revenue | 10.13 |
| Enterprise/EBITDA | -27.26 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.52 |
| Operating Margin | -0.35 |
| Return On Assets | -0.39 |
| Return On Equity | 0.82 |
| Revenue | 109.79M |
| Revenue/Share | 3.75 |
| Gross Profit | 97.34M |
| EBITDA | -135.66M |
| Net Income | -153.49M |
| Diluted EPS | -3.19 |
| Total Cash | 107.98M |
| Total Cash/Share | 2.14 |
| Total Debt | 196.13M |
| Total Debt/Equity | -1.48 |
| Current Ratio | 3.8 |
| Book Value Per Share | -2.63 |
| 52-Week Change | 120.8 |
| 52-Week High | 50.81 |
| 52-Week Low | 16.18 |
| Moving Average 50 Days | 43.7 |
| Moving Average 200 Days | 30.35 |
| Average Volume | 889,860 |
| Shares Outstanding | 48.72M |
| % Held by Institutions | 84.47 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |